CARRA', GIOVANNA
 Distribuzione geografica
Continente #
NA - Nord America 4.148
AS - Asia 2.166
EU - Europa 1.951
SA - Sud America 234
AF - Africa 45
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 5
Totale 8.573
Nazione #
US - Stati Uniti d'America 4.071
CN - Cina 757
SG - Singapore 754
IT - Italia 622
VN - Vietnam 223
FR - Francia 202
BR - Brasile 188
IE - Irlanda 180
DE - Germania 177
FI - Finlandia 153
SE - Svezia 133
JP - Giappone 104
DK - Danimarca 100
UA - Ucraina 85
AT - Austria 82
GB - Regno Unito 64
HK - Hong Kong 59
PL - Polonia 51
IN - India 48
KR - Corea 41
ID - Indonesia 36
CA - Canada 33
MX - Messico 31
NL - Olanda 25
AU - Australia 24
TW - Taiwan 20
AR - Argentina 19
BD - Bangladesh 18
IQ - Iraq 16
ZA - Sudafrica 14
TR - Turchia 13
BE - Belgio 12
EC - Ecuador 10
PT - Portogallo 10
EG - Egitto 9
PK - Pakistan 8
RU - Federazione Russa 8
SN - Senegal 8
UZ - Uzbekistan 8
NP - Nepal 7
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
GR - Grecia 6
IR - Iran 6
CH - Svizzera 5
ES - Italia 5
MO - Macao, regione amministrativa speciale della Cina 5
RO - Romania 5
TN - Tunisia 5
CL - Cile 4
EU - Europa 4
HU - Ungheria 4
IL - Israele 4
MY - Malesia 4
PH - Filippine 4
PY - Paraguay 4
BG - Bulgaria 3
CO - Colombia 3
DZ - Algeria 3
JO - Giordania 3
MA - Marocco 3
PR - Porto Rico 3
AE - Emirati Arabi Uniti 2
BT - Bhutan 2
BY - Bielorussia 2
CR - Costa Rica 2
CY - Cipro 2
JM - Giamaica 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
MN - Mongolia 2
PE - Perù 2
RS - Serbia 2
SI - Slovenia 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
VE - Venezuela 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GT - Guatemala 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MK - Macedonia 1
NO - Norvegia 1
QA - Qatar 1
SA - Arabia Saudita 1
SC - Seychelles 1
SV - El Salvador 1
SX - ???statistics.table.value.countryCode.SX??? 1
Totale 8.573
Città #
Singapore 451
Chandler 355
Ashburn 347
Beijing 335
Fairfield 327
San Jose 199
Ann Arbor 194
Santa Clara 187
Torino 181
Houston 177
Dublin 173
Woodbridge 169
Wilmington 137
Seattle 130
Cambridge 113
Turin 104
Villeurbanne 97
Dallas 90
Jacksonville 81
Nyköping 78
Pisa 77
Vienna 74
Dearborn 68
Helsinki 58
Columbus 48
Hanoi 46
Los Angeles 46
Munich 46
Dong Ket 45
Princeton 44
Warsaw 44
Hong Kong 43
Lauterbourg 42
Medford 38
Tokyo 35
Boston 34
Fremont 34
Ho Chi Minh City 34
Jakarta 34
Council Bluffs 33
The Dalles 33
Buffalo 30
New York 28
Guangzhou 27
Hangzhou 25
Nanjing 25
Milan 22
San Diego 22
Shanghai 22
Turku 21
Phoenix 20
São Paulo 19
Redwood City 18
Washington 16
Frankfurt am Main 15
Nuremberg 15
Düsseldorf 14
London 14
Seoul 14
Silver Spring 14
Taipei 14
Hefei 13
Kunming 12
Chennai 11
Da Nang 11
Orem 11
Paris 11
Redondo Beach 11
Changsha 10
San Mateo 10
Toronto 10
Boardman 9
Brussels 9
Chicago 9
Duncan 9
Haiphong 9
Hebei 9
Brooklyn 8
Falls Church 8
Mexico City 8
Nanchang 8
Piemonte 8
Upper Marlboro 8
Vestignè 8
Wuhan 8
Brasília 7
Chengdu 7
Fuzhou 7
Johannesburg 7
La Jolla 7
Malappuram 7
Ottawa 7
Rome 7
Taiyuan 7
Tashkent 7
Zhengzhou 7
Biên Hòa 6
Dhaka 6
Lappeenranta 6
Limerick 6
Totale 5.605
Nome #
Morgana acts as an oncosuppressor in chronic myeloid leukemia. 545
P53 vs NF-κB: the role of nuclear factor-kappa B in the regulation of p53 activity and vice versa 472
Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones 402
Morgana is a new oncosuppressor in CML 327
Non-Oncogene Addiction to BRD in CLL: from JQ1 Response to Resistence 272
Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma 260
BCR-ABL inactivates cytosolic PTEN through casein kinase II mediated tail phosphorylation 255
BCR-ABL Promotes PTEN Downregulation in Chronic Myeloid Leukemia. 247
Targeting the extracellular HSP90 co-chaperone Morgana inhibits cancer cell migration and promotes anti-cancer immunity 245
New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemia 238
The BCR-ABL/NF-κB signal transduction network: a long lasting relationship in Philadelphia positive Leukemias 231
A novel multiplex qrt-pcr assay to detect sars-cov-2 infection: High sensitivity and increased testing capacity 211
IκBα targeting promotes oxidative stress-dependent cell death 202
Targeting few to help hundreds: JAK, MAPK and ROCK pathways as druggable targets in atypical chronic myeloid leukemia 200
Phenotypical heterogeneity of acute myeloid leukemia in the elderly: a clue for a personalized therapy? 193
ALTERNATIVE SPLICING VARIANT COULD BE RESPONSIBLE OF MORGANA UNDER-EXPRESSION IN ACML 191
Mechanisms of p53 Functional De-Regulation: Role of the IκB-α/p53 Complex 188
INHIBITION OF USP7 INDUCES SELECTIVE CANCER CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA THROUGH PTEN AND INDEPENDENTLY FROM P53 STATUS 187
Inhibition of bromodomain and extra-terminal proteins increases sensitivity to venetoclax in chronic lymphocytic leukaemia 187
Tumor suppressors in chronic lymphocytic leukemia: From lost partners to active targets 184
A new non canonical role of IkB-alpha in chronic myleoid leukemia pathogenesis 179
NEW ALTERNATIVE PROTEIN Bcr/Abl-OOF SHOWS ONCOGENIC ACTIVITY BY ACTIVATION OF RAC AND COOPERATION WITH Bcr/Abl IN CHRONIC MYELOID LEUKEMIA. 179
Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias 179
Modeling myeloproliferative neoplasms: From mutations to mouse models and back again 176
The targetable role of herpes virus-associated ubiquitin-specific protease (HAUSP) in p190 BCR-ABL leukemia 175
Inhibition OF USP7 Induces Selective Cancer Cell Death in Chronic Lymphocytic Leukemia 164
Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBα mediated p53 nuclear exclusion 149
INHIBITION OF USP7 INDUCES GROWTH ARREST AND APOPTOSIS VIA PTEN IN CLL CELLS 149
The non-genomic loss of function of tumor suppressors: an essential role in the pathogenesis of chronic myeloid leukemia chronic phase 148
Strategies For Targeting Chronic Myeloid Leukaemia Stem Cells 146
The synergism between DHODH inhibitors and dipyridamole leads to metabolic lethality in acute myeloid leukemia 142
Tumor suppressors revival in CLL 141
A new oncogenic role of BCR-ABL/OOF in chronic myeloid leukemia pathogenesis 139
Non-Coding RNAs: The "Dark Side Matter" of the CLL Universe 139
BCR-ABL inactivates cytosolic PTEN through casein kinase II mediated tail phosphorylation. 135
HAUSP compartmentalization in chronic myeloid leukemia 134
Nuclear-cytoplasmic Shuttling in Chronic Myeloid Leukemia: Implications in Leukemia Maintenance and Therapy 132
ROLE OF HAUSP/PTEN NETWORK IN CHRONIC LYMPHOID LEUKEMIA PATHOGENESIS AND THERAPY 126
N-acetylaspartate release by glutaminolytic ovarian cancer cells sustains protumoral macrophages 122
Therapeutic inhibition of HAUSP-PTEN network in chronic lymphocytic leukemia 112
NON GENOMIC LOSS OF FUNCTION OF TUMOR SUPPRESSORS IN CML: BCR-ABL PROMOTES P53 NUCLEAR EXCLUSION THROUGH THE INTERACTION WITH IKB-ALPHA 111
IκB-α: At the crossroad between oncogenic and tumor-suppressive signals 109
The Role of PTEN in Myeloid Malignancies 96
Unleashing the Guardian: The Targetable BCR-ABL/HAUSP/PML/PTEN Network in Chronic Myeloid Leukemia 88
The p53 orbit in chronic myeloid leukemia: Time to move to patient care 68
NON GENOMIC LOSS OF FUNCTION OF TUMOR SUPPRESSORS IN CML: BCR-ABL PROMOTES P53 NUCLEAR EXCLUSION THROUGH THE INTERACTION WITH IKB-ALPHA 67
null 37
The NFKBIA amplification: an emerging molecular target for lung cancer therapy 16
Totale 8.795
Categoria #
all - tutte 23.982
article - articoli 0
book - libri 0
conference - conferenze 6.824
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.806


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021137 0 0 0 0 0 0 0 0 0 0 0 137
2021/2022880 76 49 38 89 51 60 53 49 39 81 160 135
2022/2023956 90 96 27 107 77 239 57 46 89 16 67 45
2023/2024531 44 71 28 45 41 80 29 40 9 37 55 52
2024/20251.227 18 88 61 99 239 83 59 81 140 88 113 158
2025/20262.082 250 60 189 206 263 95 354 94 245 172 93 61
Totale 8.795